INmune Bio Inc. Publishes Novel Biology on Natural Killer Cancer Immunotherapy INKmune™ in the Journal for ImmunoTherapy of Cancer

Publication of detailed analysis on INKmune biology compared to cytokine stimulated cells demonstrates important anti-tumor memory like NK cell characteristics Additionally, the paper highlights the enhanced metabolic function of the NK cells primed by INKmuneTM, predicting improved performance in the tumor microenvironment (TME). "This research is particularly noteworthy as NK cell dysfunction in the TME is often due to impaired metabolism," stated RJ Tesi, INmune's CEO. "The findings suggest that INKmune ...